Try our Advanced Search for more refined results
Sabbagh v. Cell Therapeutics Inc et al
Case Number:
2:10-cv-00414
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Brower Piven
- Fox Rothschild
- Hagens Berman
- Kahn Swick
- Karr Tuttle
- Keller Rohrback
- Kessler Topaz
- Lane Powell
- Lieff Cabraser
- O'Melveny & Myers
- Robbins Geller
- Ropes & Gray
- Wilk Auslander
- Wilson Sonsini
Companies
Sectors & Industries:
-
February 14, 2012
Cell Therapeutics Settles Investor Lawsuit For $19M
Seattle-based biotechnology company Cell Therapeutics Inc. agreed to pay $19 million to settle a class action by investors who contended the company's stock price was artificially inflated due to misleading statements about a pipeline drug, according to a Tuesday court filing.
-
February 07, 2011
Cell Therapeutics Fails To Nix Investor Class Action
A federal judge has refused to dismiss a consolidated class action accusing biopharmaceutical company Cell Therapeutics Inc. and its executives of misleading investors into believing the U.S. Food and Drug Administration was poised to approve a new cancer treatment product.